Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Gallstones.

W A Hoogerwerf1, R D Soloway

  • 1Division of Gastroenterology, University of Texas Medical Branch, Galveston, Texas 77555, USA.

Current Opinion in Gastroenterology
|October 7, 2006
PubMed
Summary
This summary is machine-generated.

Recent advances in gallstone disease highlight the role of Phospholipase A(2)-II in cholesterol stone formation. Ursodeoxycholic acid shows promise in halting stone formation and may be effective with simvastatin.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Gallstones.

Current opinion in gastroenterology·2006
Same author

Prokineticin 1 inhibits spontaneous giant contractions in the murine proximal colon through nitric oxide release.

Neurogastroenterology and motility·2006
Same author

A decade of botulinum toxin injections for achalasia: where do we stand?

Endoscopy·2002
Same author

The interaction of Cu2 + ions and NaDC micelles.

Spectrochimica acta. Part A, Molecular and biomolecular spectroscopy·2002
Same author

Lansoprazole provided more effective and faster relief for heartburn than did omeprazole in erosive esophagitis.

ACP journal club·2002
Same author

Cesium cholate: determination of X-ray crystal structure indicates participation of the ring hydroxyl groups in metal binding.

Steroids·2002
Same journal

Endoscopic techniques to minimize gastroesophageal reflux during peroral endoscopic myotomy.

Current opinion in gastroenterology·2026
Same journal

Postendoscopy esophageal adenocarcinoma and neoplasia: current status and future directions.

Current opinion in gastroenterology·2026
Same journal

The complement system in inflammatory bowel disease: from early observations to emerging frontiers.

Current opinion in gastroenterology·2026
Same journal

Goblet cell-associated antigen passages in health and disease.

Current opinion in gastroenterology·2026
Same journal

Inflammatory bowel diseases 2026: form, function and therapeutic considerations for the epithelial barrier.

Current opinion in gastroenterology·2026
Same journal

Dietary protein as a regulator of colitis and colorectal cancer.

Current opinion in gastroenterology·2026
See all related articles

Area of Science:

  • Gastroenterology
  • Hepatology
  • Epidemiology

Background:

  • Gallstone disease remains a significant health concern with ongoing research into its complex etiology.
  • Understanding the factors influencing gallstone formation is crucial for developing effective prevention and treatment strategies.

Purpose of the Study:

  • To review recent advancements in the epidemiology, pathogenesis, and medical treatment of gallstone disease.
  • To explore the role of specific enzymes and infections in gallstone formation.
  • To evaluate novel therapeutic approaches for gallstone management.

Main Methods:

  • Literature review of studies published within the past year on gallstone disease.
  • Analysis of research on the pathogenesis of cholesterol gallstones.

Related Experiment Videos

  • Evaluation of clinical data on the efficacy of ursodeoxycholic acid and combination therapies.

    • Main Results:

    • The role of rapid weight reduction in gallstone formation remains under investigation.
    • Phospholipase A(2)-II is implicated in the pathogenesis of multiple cholesterol gallstones.
    • Ursodeoxycholic acid may inhibit gallstone formation via anti-inflammatory mechanisms.
    • Bacterial biofilms may contribute to gallstone development.
    • Combination therapy with ursodeoxycholic acid and simvastatin shows potential for gallstone resolution and prevention.

    Conclusions:

    • Further research is needed to clarify the link between rapid weight loss and gallstone formation.
    • Targeting Phospholipase A(2)-II and inflammatory pathways may offer new therapeutic avenues.
    • Combination therapy with ursodeoxycholic acid and simvastatin warrants larger clinical trials for validation.